Past Forums | World Medical Innovation Forum - Artificial Intelligence
WMIF Main Site

Past Forums

[wpbb post:title]

Past Forums

Artificial Intelligence

April 23-25, 2018


April 25-27, 2016


May 1-3, 2017


April 27-29, 2015


March 27, 2017

Past Forum Keynoters


  • Jani Ahonala
    CEO, Noona Healthcare
  • Stéphane Bancel
    CEO, Moderna Therapeutics
  • George Barrett
    CEO, Cardinal Health
  • Fabien Beckers, PhD
    CEO, Arterys
  • Mark Bertolini
    CEO, Aetna
  • Katrine Bosley
    CEO, Editas Medicine
  • Robert Bradway
    CEO, Amgen
  • Nancy Brown
    CEO, American Heart Association
  • Dan Burton
    CEO, Health Catalyst
  • Giovanni Caforio, MD
    CEO, Bristol-Myers Squibb
  • Robert Califf, MD
    Commissioner (former), Food and Drug Administration
  • Peter Chiarelli
    CEO, One Mind for Research
  • Tony Coles, MD
    CEO, Yumanity Therapeutics
  • Patrick Conway, MD
    CEO, BCBS of North Carolina
  • Marc de Garidel
    CEO, Ipsen
  • Louis DeGennaro, PhD
    President and CEO, The Leukemia & Lymphoma Society
  • Susan Dentzer
    CEO, Network for Excellence in Health Innovation
  • Keith Dionne, PhD
    CEO, Constellation Pharmaceuticals
  • Deborah Dunsire, MD
    CEO, XTuit Pharmaceuticals
  • Helmy Eltoukhy, PhD
    CEO, Guardant Health
  • Maurice Ferre, MD
    CEO, Insightec
  • Frank Fischer
    CEO, NeuroPace
  • John Flannery
    CEO, GE Healthcare
  • Paul Fonteyne
    CEO, Boehringer-Ingelheim USA
  • Peter Ford
    Founder and CEO, Control Bionics
  • Richard Gonzalez
    CEO, AbbVie
  • Colin Hill
    CEO, GNS Healthcare
  • Andew Hopkins
    CEO, Exscientia
  • Jensen Huang
  • Thomas Hughes, PhD
    CEO, Zafgen
  • Jackie Hunter, PhD
    CEO, Benevolent AI
  • Jeff Immelt
    CEO, General Electric
  • Omar Ishrak, PhD
    CEO, Medtronic
  • Joseph Jachinowski
    CEO, Mevion Medical Systems
  • Joseph Jimenez
    CEO, Novartis
  • Karim Karti
    CEO, GE Healthcare Imaging
  • Krishna Kumar
    CEO, Emerging Businesses, Philips
  • John Lechleiter, PhD
    Chairman, Eli Lilly and Company
  • David Lee
    CEO, Lumicell
  • Jeffrey Leiden, MD, PhD
    CEO, Vertex Pharmaceuticals
  • Noga Leviner
    CEO, Picnic Health
  • Michael Mahoney
    CEO, Boston Scientific
  • John Maraganore, PhD
    CEO, Alnylam
  • Corey McCann, MD, PhD
    Founder and CEO, Pear Therapeutics
  • Martin McGlynn
    CEO, StemCells
  • Clive Meanwell, MD, PhD
    CEO, The Medicines Company
  • David Meeker, MD
    CEO, Genzyme
  • Michael Minogue
    CEO, Abiomed
  • Bernd Montag, PhD
    CEO, Siemens Healthineers
  • Briggs Morrison, MD
    CEO, Syndax Pharmaceuticals
  • Robert Mulroy
    CEO, Merrimack Pharmaceuticals
  • Michael Mussallem
    CEO, Edwards Lifesciences
  • Vasant Narasimhan, MD
    CEO, Novartis
  • Diana Nole
    CEO, Wolters Kluwer Health
  • Gabriel Otte
    CEO, Freenome
  • Michael Pellini, PhD
    CEO, Foundation Medicine
  • Gary Reedy
    CEO, American Cancer Society
  • Jonathan Rennert
    CEO, ZOLL Medical
  • Paul Ricci
    Former Chairman and CEO, Nuance Communications
  • Timothy Ring
    CEO, Bard
  • Johnathan Rothberg, PhD
    Founder and CEO, Butterfly Network
  • Judy Salerno, MD
    CEO, Susan G. Komen for the Cure
  • Satish Sanan
    CEO, Inspirata
  • George Scangos, PhD
    CEO, Biogen
  • Dale Schenk, PhD
    CEO, Prothena
  • Todd Sherer, PhD
    CEO, The Michael J. Fox Foundation for Parkinson’s Research
  • Sue Siegel
    CEO, GE Ventures & healthymagination
  • Nancy Simonian, MD
    CEO, Syros Pharmaceuticals
  • Punit Soni
    CEO, Robin AI
  • David Torchiana, MD
    CEO, Partners HealthCare
  • Steven Tregay, PhD
    CEO, Forma Therapeutics
  • Chuck Wilson, PhD
    CEO, Unum Therapeutics
  • Dow Wilson
    CEO, Varian Medical Systems
  • Frans van Houten
    CEO, Philips

Executives, Investors, Philanthropic and Government Leads

  • Amy Abernethy, MD, PhD
    CMO, CSO & SVP Oncology, Flitiron Health
  • Philip Adamson, MD
    VP and Medical Director, Abbott
  • Julia Beaver, MD
    Acting Clinical Team Leader, Division of Oncology Products 1, CDER, FDA
  • Roy Beveridge, MD
    SVP and CMO, Humana
  • Morris Birnbaum, MD, PhD
    SVP and CSO, CVMET, Pfizer
  • Daniel Bloomfield, MD
    SVP, Global Clinical Research, Therapeutic Area Head, Cardiometabolic & Womens Health, MRL Lead, China R&D, Merck
  • Jay Bradner, MD
    President, Novartis Institutes for Biomedical Research
  • Troy Brennan, MD
    EVP and CMO, CVS Health
  • Terri Bresenham
    Chief Innovation Officer, GE Healthcare
  • Carsten Brunn, PhD
    Head of Pharmaceuticals, Americas Region, Bayer
  • Iain Buchan, MD
    Director of Healthcare Research, Microsoft Research
  • Hon, Sylvia Mathews Burwell
    Secretary, U.S. Health and Human Services
  • Doug Cole, MD
    General Partner, Flagship Ventures
  • Meryl Comer
    President, Geoffrey Beene Foundation Alzheimer’s Initiative
  • Robert Copeland, PhD
    President, Research and CSO, Epizyme
  • Newt Crenshaw
    VP, North America Oncology, Eli Lilly and Company
  • Francis Cuss, MD
    EVO and CSO, R&D, Bristol-Myers Squibb
  • Leonard D’Avolio, PhD
    CEO, Cyft, Inc.
  • Michael Dale
    Divisional VP and General Manager, Structural Heart, Abbott
  • Thomas Daniel, MD
    Chairman, Celgene Research
  • Jens Eckstein, PhD
    President, SR One
  • Steve Fawell, PhD
    VP, Head Oncology iScience, AstraZeneca
  • Robert Ford
    EVP, Medical Devices, Abbott
  • Jean-François Formela, MD
    Partner, Atlas Venture
  • Colleen Fowler
    VP, GM, AF Solutions, Medtronic
  • Pete Frates
    Champion, ALS Ice Bucket Challenge
  • Jamie Freedman, MD, PhD
    SVP, Global Clinical Development, Medimmune
  • Mark Frohlich, MD
    EVP, Portfolio Strategy, Juno Therapeutics
  • Gary Gibbons, MD
    Director, National Heart,&bnsp;Lung, and Blood Institute (NHLBI)
  • Kathy Giusti
    Founder, MMRF and Multiple Myeloma Research Consortium
  • Corey Goodman, PhD
    Managing Partner, venBio
  • Jeffrey Gulcher, MD, PhD
    President and CSO, NextCODE Health
  • Adele Gulfo
    EVP & Head, Global Commercial Development, Mylan; Director, Bemis, Inc.
  • Atul Gawande, MD
    Ariadne Labs; Samuel O. Thier Professor of Surgery, HMS; Surgeon, BWH
  • Sean Harper, MD
    EVP, R&D, Amgen
  • Seth Hain
    Director, Analytics & Machine Learning, Epic
  • William Hait, MD, PhD
    Global Head, Janssen Research & Development, J&J
  • Ludovic Helfgott
    Global VP, Cardiovascular, Renal and Metabolism, AstraZeneca
  • Paul Hudson
    President, AstraZeneca US and EVP, North America
  • Michael Hutton, PhD
    CSO, Neurodegenerative Diseases, Eli Lilly and Company
  • Rajiv Kaul
    Select Biotechnology Portfolio and Advisor Biotechnology Fund, Fidelity Investments
  • Hiroyuki Kawabata
    Director, Health & Welfare Department, JETRO New York
  • Allison Kean, MD
    CV Therapeutic Area Lead, Global Business Development, Pfizer
  • John Kelly, PhD
    SVP, Cognitive Solutions and Research, IBM
  • Aarif Khakoo, MD
    VP Research, Cardiometabolic Disorders Therapeutic Area Head, Site Head Amgen San Francisco, Amgen
  • Maria Koehler, MD, PhD
    VP, Strategy, Innovation and Collaborations, Pfizer Oncology Business Unit
  • Lothar Krinke, PhD
    VP and GM, Brain Modulation, Medtronic
  • Paul LaViolette
    Managing Partner and COO, SV Life Sciences Advisers
  • Peter Lebowitz, MD, PhD
    Global Therapeutic Area Head, Oncology, Janssen R&D
  • Jonathan Leff
    Partner, Deerfield Management
  • Gillian Leng, MD
    Deputy Chief Executive, Director of Health and Social Care, National Institute for Health and Care Excellence
  • John Lepore, MD
    SVP, R&D Pipeline, GlaxoSmithKline
  • Dean Li, MD, PhD
    VP, Head Translational Medicine, Merck
  • Geoffrey Ling, MD, PhD
    Director, Biological Technologies Office, DARPA
  • Thomas Lynch, MD
    EVP and CSO, R&D, Bristol-Myers Squibb
  • Lisa Maki
    Co-Founder, Director, PokitDok
  • Misti Malone, PhD
    Chief, Peripheral Interventional Devices Branch, Food and Drug Administration
  • Shaden Marzouk, MD
    CMO, Cardinal Health
  • Henry McCance
    Chairman Emeritus, Greylock Partners, CO-Founder, Cure Alzheimer’s Fund
  • Jessica Mega, MD
    CMO, Verily
  • Professor Ian Meredith, PhD
    EVP, Global CMO, Boston Scientific
  • Jeff Mirviss
    SVP and President, Peripheral Interventions, Boston Scientific
  • Greg Moore, MD, PhD
    VP, Healthcare, Google Cloud
  • Ryuichi Morishita, MD, PhD
    Founder, AnGes
  • Alan Moses, MD
    SVP, Global CMO, Novo Nordisk
  • Mark Murcko, PhD
    CSO, Relay Therapeutics
  • Amir Nashat, PhD
    Managing Partner, Polaris Partners
  • Peter Orszag, PhD
    Vice Chairman, Investment Banking and Managing Director, Lazard Freres
  • Vijay Pande
    Partner, Andreessen Horowitz
  • Georgia Papathomas, PhD
    SVP, Global Head of Data Sciences, Johnson & Johnson
  • Ora Pescovitz, MD
    SVP and US Medical Leader, Eli Lilly and Company
  • Jonathan Plehn, MD
    VP Cardiovascular Medicine, Covance
  • Miri Polachek
    Executive Director, Israel Brain Technologies
  • Amy Pollack, MD
    CMO & VP Global Medical Affairs for the Early Technologies Business Group/Minimally Invasive Technology Innovations (MITG), Medtronic
  • Sy Pretorius, MD
    SVP & CSO, PAREXEL International
  • David Reese, MD
    SVP, Translational Sciences, Amgen
  • Alessandro Riva, MD
    Global Head, Oncology Development and Medical Affairs, Novartis Oncology
  • James Robinson
    President, Americas Operations, Astellas
  • Ann Romney
    Global Ambassador, Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital
  • Bruce Rosengard, MD
    Chief Medical Science and Technology Officer, Johnson & Johnson Medical Devices Companies
  • Michael Rousseau
    President, Cardiovascular and Neuromodulation, Abbott
  • Sean Salmon
    SVP and President, Coronary & Structural Heart, Medtronic
  • Alfred Sandrock, MD, PhD
    Group SVP, CMO, Biogen
  • Lewis Sandy, MD
    EVP, Clinical Advancement, UnitedHealth Group
  • Joseph Scheeren, PharmD
    Senior Advisor, R&D, Bayer
  • Darryle Schoepp, PhD
    VP and Therapeutic Area Head, Neuroscience Early Development and Discovery Sciences, Merck Research Laboratories
  • William Sellers, MD
    VP and Global Head of Oncology, Novartis Institutes for BioMedical Research
  • Sue Siegel
    CIO and CEO, Business Innovations, GE
  • Andy Slavitt
    Acting Administrator, CMS
  • Craig Sponseller, MD
    CMO, Kowa Pharmaceuticals America
  • Norman Stockbridge, MD, PhD
    Director, Division of Cardiovascular and Renal Products, Food and Drug Administration
  • Bruno Strigini
    President, Novartis Oncology
  • Tamara Syrek Jensen
    Director, Coverage and Analysis Group, CMS
  • Eiji Tanaka, PhD
    President, Head of Global Business Development, Mitsubishi Tanabe Pharma Holdings America, Inc.
  • Robert Tepper, MD
    Partner, Third Rock Ventures, Adjunct Professor, HMS
  • Claire Thom, PharmD
    SVP, Global Oncology Development, Astellas
  • James Topper, MD, PhD
    Managing General Partner, Frazier Healthcare Partners
  • Susan Tousi
    SVP, Product Development, Illumina, Inc.
  • Timothy Tuttle, PhD
    CTO, Cognitive Collaboration Group, Cisco
  • Paul Underwood, MD
    Medical Director, Boston Scientific
  • Mike Vasconcelles, MD
    CMO, Unum Therapeutics
  • Ajay Verma, MD, PhD
    VP, Experimental Medicine, Biogen
  • Christopher Viehbacher
    Managing Partner, Gurnet Point Capital
  • Seema Verma
    Administrator, Centers for Medicare and Medicaid Services
  • Jeff Walker
    Vice-Chair, United Nations Envoy’s Office for Health Finance and Malaria
  • Scott Wasserman, MD
    VP, Global Development, Amgen

Popular Panels

2018 WMIF
Fireside Chat: Vasant Narasimhan, MD, CEO, Novartis

  • Moderator: Gregg Meyer, MD, Chief Clinical Officer, PHS; Professor of Medicine, MGH and HMS
  • Vasant Narasimhan, MD, CEO, Novartis

2015 WMIF
Gene Editing, Gene Therapy, and the Eye as a Gateway

  • Moderator: Jennifer Joe, MD, CEO, Medstro, Editor-In-Chief, MedTech Boston
  • Katrine Bosley, CEO, Editas Medicine
  • Eric Pierce, MD, PhD, Director, Retinal Degenerations Service, Massachusetts Eye and Ear; Solman and Libe Friedman Associate Professor of Ophthalmology, Harvard Medical School
  • Philip Gregory, D. Phil, Senior Vice President, Research and CSO, Sangamo BioSciences
  • David Meeker, MD, CEO, Genzyme

2016 WMIF
Fireside Chat: Joseph Jimenez, CEO, Novartis

  • Moderator: Gregg Meyer, MD, Chief Clinical Officer, Partners HealthCare
  • Joseph Jimenez, CEO, Novartis

2016 WMIF
Immunotherapy I: Checkpoint Activation and Cancer Vaccines

  • Moderator: Nir Hacohen, PhD, Immunologist, MGH Center for Immunology and Inflammatory Diseases, MGH Research Scholar, Associate Professor, Medicine, Harvard Medical School
  • Thomas Daniel, MD, Chairman, Celgene Research
  • Glenn Dranoff, MD, Global Head of Exploratory Immuno-Oncology, Novartis Institutes for Biomedical Research
  • Robert Mulroy, President and CEO, Merrimack Pharmaceuticals
  • David Reese, MD, Senior Vice President, Translational Sciences, Amgen
  • Scott Rodig, MD, PhD, Associate Professor, BWH
  • Arlene Sharpe, MD, PhD, Leader, Cancer Immunology, BWH, DFCI, George Fabyan Professor of Comparative Pathology, Harvard Medical School

2017 WMIF
1:1 Fireside Chat: Omar Ishrak, PhD, CEO, Medtronic

  • Moderator: Paul LaViolette, Managing Partner & COO, SV Life Sciences Advisers
  • Omar Ishrak, PhD, CEO, Medtronic

2018 WMIF
1:1 Fireside Chat: Jensen Huang, CEO, NVIDIA

  • Introduction: Scott Sperling, Co-President, Thomas H Lee Partners; Chairman of the Board of Directors, PHS
  • Moderator: Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
  • Jensen Huang, CEO, NVIDIA
View All

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA